Organization
Megan Waldrop
2 clinical trials
Clinical trial
Phase I/IIa Systemic Gene Delivery Clinical Trial of scAAV9.U7.ACCA for Exon 2 Duplication-Associated Duchenne Muscular DystrophyStatus: Active (not recruiting), Estimated PCD: 2023-11-19
Clinical trial
Phase I/IIa Intrathecal Gene Delivery Clinical Trial for IGHMBP2-Related DiseasesStatus: , Estimated PCD: 2026-11-01